XML 53 R36.htm IDEA: XBRL DOCUMENT v3.25.4
Stockholders Equity (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2025
Dec. 31, 2024
Stockholders Equity    
Summary of Changes in Restricted Shares  

 

 

Restricted Stock Award

 

 

Weighted -Average Grant Price

 

Balance, December 31, 2022

 

 

11,666,667

 

 

$0.03

 

Granted

 

 

-

 

 

 

-

 

Vested

 

 

-

 

 

 

-

 

Forfeited

 

 

-

 

 

 

-

 

Balance, December 31, 2023

 

 

11,666,667

 

 

$0.03

 

Granted

 

 

-

 

 

 

-

 

Vested

 

 

-

 

 

 

-

 

Cancelled

 

 

(10,833,334)

 

 

0.03

 

Balance, December 31, 2024

 

 

833,333

 

 

$0.03

 

Schedule of assumptions used for fair value compensation

2025

 

Derived service period

 

0.51 – 0.78 year

 

Risk-free interest rate

 

3.65 - 3.97

Stock price at valuation date

$

5.89 - 12.00

 

Expected average volatility

 

108.5 - 151.0

First Capitalization Thresholder per share price

$

6.85 - 14.28

 

Second Capitalization Thresholder per share price

8.56 - 19.02

 

Third Capitalization Thresholder per share price

$

11.42 - 23.82

 

Fourth Capitalization Thresholder per share price

$

 14.27 - 28.56

 

 
Schedule of assumptions of warrants

 

 

September 30,

 

 

 

2025

 

Expected term

 

5.00 years

 

Expected average volatility

 

49.0% - 228

Risk-free interest rate

 

3.82% - 4.29

Expected dividend yield

 

 

-

 

 

 

2024

 

Expected term

 

5.00 years

 

Expected average volatility

 

239-251

Expected dividend yield

 

 

-

 

Risk-free interest rate

 

3.79–4.30

Summary of warrants activity

 

 

Warrants Outstanding

 

 

 Weighted Average

 

 

 

 

 

 

Weighted

 

 

Remaining

 

 

 

Shares

 

 

Average Exercise Price

 

 

Contractual life (in years)

 

 

 

 

 

 

 

 

 

 

 

Outstanding, December 31, 2024

 

 

270,010

 

 

$0.50

 

 

 

4.61

 

Granted

 

 

2,434,324

 

 

 

3.15

 

 

 

5.03

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

Canceled

 

 

(778,566)

 

 

0.43

 

 

 

4.65

 

Outstanding, September 30, 2025

 

 

1,925,768

 

 

$4.22

 

 

 

4.57

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable, September 30, 2025

 

 

1,925,768

 

 

$4.22

 

 

 

4.57

 

 

 

Warrants Outstanding

 

 

 

 

 

 

 

 

 

Weighted Average

 

 

Weighted Average Remaining

 

 

 

Shares

 

 

Exercise Price

 

 

Contractual life (in years)

 

 

 

 

 

 

 

 

 

 

 

Outstanding, December 31, 2023

 

 

-

 

 

$-

 

 

 

-

 

Granted

 

 

270,010

 

 

 

3.00

 

 

 

5.00

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

Forfeited/canceled

 

 

-

 

 

 

-

 

 

 

-

 

Outstanding, December 31, 2024

 

 

270,010

 

 

$3.00

 

 

 

4.61

 

Schedule of management stock compensation

Market capitalization

for 30

consecutive days

 

 

Consulting agreement

CEO resigned on

October 1, 2025

(Shares)

 

 

Consulting agreement

Director

(Shares)

 

 

Employment agreement

COO

(Shares)

 

$

120,000,000

 

 

 70,000 series C preferred stock

 

 

 70,000 series C preferred stock

 

 

 

-

 

$

150,000,000

 

 

 70,000 series C preferred stock

 

 

 70,000 series C preferred stock

 

 

37,500 common stock

 

$

200,000,000

 

 

 70,000 series C preferred stock

 

 

 70,000 series C preferred stock

 

 

37,500 common stock

 

$

250,000,000

 

 

 70,000 series C preferred stock

 

 

 70,000 series C preferred stock

 

 

37,500 common stock

 

$

300,000,000

 

 

 

-

 

 

 

-

 

 

37,500 common stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value ($)

 

 

$1,932,000

 

 

$3,165,000

 

 

$1,740,000